Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kura Oncology (KURA)

Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kura Oncology 12730 HIGH BLUFF DRIVE SUITE 400 SAN DIEGO CA 92130 USA

www.kuraoncology.com P: 858-500-8800

Description:

Kura Oncology, Inc. is a biopharmaceutical company. The company is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers. Its product pipeline includes small molecule drug candidates which are in different clinical trial consists of Tipifarnib-HRAS, Tipifarnib-PTCL, ERK inhibitor program and Menin MLL inhibitor program. Kura Oncology, Inc. is headquartered in La Jolla, California.

Key Statistics

Overview:

Market Capitalization, $K 1,428,394
Enterprise Value, $K 1,400,404
Shares Outstanding, K 76,181
Annual Sales, $ 0 K
Annual Net Income, $ -152,630 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -42,790 K
EBIT, $ -165,800 K
EBITDA, $ -174,370 K
60-Month Beta 0.85
% of Insider Shareholders 5.50%
Float, K 71,991
% Float 94.50%
Short Volume Ratio 0.72

Growth:

1-Year Return 77.07%
3-Year Return -29.45%
5-Year Return 20.41%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -20.93%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.55 on 02/27/24
Latest Earnings Date 05/08/24
Earnings Per Share ttm -2.08
EPS Growth vs. Prev Qtr -10.00%
EPS Growth vs. Prev Year -12.24%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KURA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -36.30%
Return-on-Assets % -33.12%
Profit Margin % 0.00%
Debt/Equity 0.02
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.40
Book Value/Share 5.35
Interest Coverage -97.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar